OncoMatch/Clinical Trials/NCT07651553

Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision

Official title: A Prospective, Randomized, Parallel-Controlled, Superiority Clinical Study Comparing Transanal Total Mesorectal Excision (taTME) and Robot-Assisted Total Mesorectal Excision (RTME) in the Treatment of Low Rectal Cancer

Is NCT07651553 recruiting? Yes, currently enrolling (Oct 2026). This NA trial studies non-drug interventions for rectal cancer patients.

TME remains standard treatment for rectal cancer. Both Robotic TME and taTME are innovative surgical techniques with potential advantages in low rectal cancer. To date, no clinical studies have directly compared the conversion and complication rates between taTME and RTME in this population. Therefore, the investigators propose to conduct a prospective, randomized, parallel-controlled clinical trial comparing taTME with RTME for low rectal cancer, aiming to provide high-level evidence for surgical decision-making and benefit more patients.